Directory
>
Eva Stroynowski Otte
Eva Stroynowski Otte
Senior Vice President, Investor Relations and Corporate Affairs | Omega Therapeutics
Boston, Massachusetts, United States
Eva Stroynowski Otte
Summary
Eva Stroynowski Otte is an accomplished Senior Vice President specializing in Investor Relations and Corporate Affairs at Omega Therapeutics, with a robust background in biotechnology and clinical research. She has a proven track record in strategic communications, excelling in corporate communications, investor relations, and public relations. With extensive experience in managing R&D communications and navigating FDA regulatory actions, Eva is adept at overseeing product launches and engaging with patients and stakeholders. Her leadership roles at notable organizations like Alkermes and Olema Oncology highlight her expertise in corporate affairs and investor relations. Eva's academic credentials include a Master's in Public Health from Tufts University and a Bachelor's from Carnegie Mellon, further enhancing her professional profile. She is known for her ability to foster team development and drive change management initiatives, making her a key player in her field. Eva's commitment to advancing health communications reflects her passion for improving patient engagement and brand reputation in the pharmaceutical industry.
Eva Stroynowski Otte
Work Experience
Senior Vice President, Investor Relations and Corporate Affairs at
Omega Therapeutics
September 2022 - Present
Vice President, Communications and Investor Relations at
Olema Oncology
April 2021 - August 2022
Vice President of Public Affairs at
Alkermes
October 2019 - March 2021
Vice President, Product and R&D Communications, Public Affairs at
Alkermes
January 2019 - October 2019
Senior Director, Investor Relations at
Alkermes
July 2017 - January 2019
Director, Investor Relations at
Alkermes
February 2016 - June 2017
Associate Director, Corporate Communications at
Alkermes
April 2007 - January 2016
Health Communications Specialist at
The Medical Foundation
January 2006 - January 2007
Clinical Research Assistant at
Harvard University
August 2004 - August 2006
Eva Stroynowski Otte
Education
Tufts University School of Medicine, Mph
January 2006 - January 2008
Carnegie Mellon University, Bs
January 2000 - January 2004
Frequently Asked Questions about Eva Stroynowski Otte
What is Eva Stroynowski Otte email address?
Eva Stroynowski Otte's primary email address is ***@olemapharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Eva Stroynowski Otte work for?
Eva Stroynowski Otte is a Senior Vice President, Investor Relations and Corporate Affairs at Omega Therapeutics, a company specializing in Commercial physical research.
Where Eva Stroynowski Otte graduated from?
Eva Stroynowski Otte holds a degree in Health Communications from Tufts University School of Medicine.
How can I directly contact Eva Stroynowski Otte?
To contact Eva Stroynowski Otte directly, you can use the email address ***@olemapharma.com. Complete contact information is available upon registration with Muraena.
Who is Eva Stroynowski Otte?
Eva Stroynowski Otte is an accomplished Senior Vice President specializing in Investor Relations and Corporate Affairs at Omega Therapeutics, with a robust background in biotechnology and clinical research. She has a proven track record in strategic communications, excelling in corporate communications, investor relations, and public relations. With extensive experience in managing R&D communications and navigating FDA regulatory actions, Eva is adept at overseeing product launches and engaging with patients and stakeholders. Her leadership roles at notable organizations like Alkermes and Olema Oncology highlight her expertise in corporate affairs and investor relations. Eva's academic credentials include a Master's in Public Health from Tufts University and a Bachelor's from Carnegie Mellon, further enhancing her professional profile. She is known for her ability to foster team development and drive change management initiatives, making her a key player in her field. Eva's commitment to advancing health communications reflects her passion for improving patient engagement and brand reputation in the pharmaceutical industry.
Eva`s contact details
***@olemapharma.com
*****@omegatherapeutics.com
Colleagues
Executive Director, Finance
Chief Legal and Administrative Officer
VP Data & IT
Chief Financial Officer
Vice President, Strategy
SVP of Finance & CAO
Chief of Staff
Vice President, Head of Computational Genomics and Data Sciences
Vice President of Technical Operations
Senior Vice President, Discovery and Early Development